| Sep 30, 2026 | Blue Cross Blue Shield of Massachusetts | Gene Therapy for Spinal Muscular Atrophy (SMA) Prior Authorization Request FormPayerPolicy · BCBSMA-085-2088B16F8A | New policy |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Massachusetts | Gene Therapies for Spinal Muscular Atrophy (SMA)PayerPolicy · BCBSMA-008-FFBEB6136A | New policy |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | DRUG COATED BALLOON FOR BENIGN PROSTATIC HYPERPLASIA LOWER URINARY TRACT SYMPTOMS & URETHRAL STRICTURES (I.E., OPTILUME DRUG COATED BALLOON) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209362-A6764802A3 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SCREENING FOR LUNG CANCER AND PULMONARY NODULE EVALUATION USING LOW DOSE COMPUTED TOMOGRAPHY (CT) SCANNING AND COMPUTER AIDED DETECTION (CAD) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209379-FA6621C8D2 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MULTIMARKER SERUM-BASED TESTING RELATED TO OVARIAN CANCER (E.G., OVA1, OVERA, OVAWATCH, GLYCOKNOW OVARIAN AND ROMA TESTING) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209378-392273413B | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY-MODULATED RADIATION THERAPY (IMRT) AND IMAGE GUIDED RADIATION THERAPY (IGRT): CANCER OF THE HEAD AND NECK OR THYROID (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209370-FF9694DE6D | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY MODULATED RADIATION THERAPY (IMRT) AND IMAGE GUIDED RADIATION THERAPY (IGRT): CENTRAL NERVOUS SYSTEM TUMORS (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209371-61F868F3A7 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR FMR1 VARIANTS (INCLUDING FRAGILE X SYNDROME) AND FMR2 VARIANTS (INCLUDING FRAGILE XE SYNDROME) (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210508-A97EB2D942 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY-MODULATED RADIATION THERAPY (IMRT) AND IMAGE GUIDED RADIATION THERAPY (IGRT): ABDOMEN, PELVIS, AND CHEST (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209368-ED8EF1AD56 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CONTRAST-ENHANCED COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA, CCTA, MDCT, MSCT) OF THE HEART AND/OR CORONARY ARTERIES (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209363-F786AACAB5 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY MODULATED RADIATION THERAPY (IMRT) AND IMAGE GUIDED RADIATION THERAPY (IGRT) OF THE BREAST AND LUNG (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209369-F16B710492 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE TURNOVER MARKERS FOR DIAGNOSIS AND MANAGEMENT OF OSTEOPOROSIS AND DISEASES ASSOCIATED WITH HIGH BONE TURNOVER (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210517-4738A948E6 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ORTHOPEDIC APPLICATIONS OF STEM-CELL THERAPY (INCLUDING AUTOLOGOUS STEM CELLS USED WITH ALLOGRAFTS AND BONE SUBSTITUTES) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194064-DECCC9A84D | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CIRCULATING TUMOR DNA FOR MANAGEMENT OF NON-SMALL CELL LUNG CANCER (LIQUID BIOPSY) (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210513-81150D6F78 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IN-OFFICE NEEDLE ARTHROSCOPY (E.G., MI-EYE 2, MI-EYE 3 NEEDLESCOPE WITH CANNULA, AND VISIONSCOPE) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2196216-E7B2A306B1 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR FLT3, NPM1, CEBPA, IDH1 AND IDH2 VARIANTS IN ACUTE MYELOID LEUKEMIA (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210507-45B34DD021 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING-ASSAYS OF GENETIC EXPRESSION IN TUMOR TISSUE AS A TECHNIQUE TO HELP GUIDE DECISION-MAKING IN PATIENTS WITH BREAST CANCERPayerPolicy · BCBSM-86868-3CD924DD66 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY-MODULATED RADIATION THERAPY (IMRT) AND IMAGE-GUIDED RADIATION THERAPY (IGRT) OF THE PROSTATE (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209367-D3D4CE1BF2 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW TRANSPLANT - HEMATOPOIETIC CELL TRANSPLANTATION FOR EPITHELIAL AND SMALL CELL OVARIAN CANCER (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210520-A32040120C | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR LYNCH SYNDROME AND OTHER INHERITED COLON CANCER SYNDROMES (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209374-F4002587D8 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LABORATORY TESTS POST TRANSPLANT (KIDNEY, HEART, AND LUNG) AND FOR HEART FAILURE (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210516-1AB65D2F68 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LIGHT AND LASER THERAPY FOR VITILIGO AND ECZEMA (INCLUDING FRAGILE XE SYNDROME) (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210509-4F57AFA1F1 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GROWING RODS FOR SCOLIOSIS (E.G., MAGEC SPINAL BRACING AND DISTRACTION SYSTEM) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209376-52473931AB | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT-HCT GENE THERAPIES FOR SICKLE CELL DISEASE (AUTOLOGOUS) (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210518-B6A69F782D | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - MALIGNANT GLIOMAS INCLUDING MGMT PROMOTER METHYLATION (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209375-0A9FD2B928 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RADIOFREQUENCY ABLATION OF PERIPHERAL NERVES TO TREAT PAIN INCLUDING COOLIEF COOLED RF - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194668-923B2A3344 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY WITH SELECTIVE NONINVASIVE FRACTIONAL FLOW RESERVE (FFRCT) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195974-3B6794D6A4 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY MODULATED RADIATION THERAPY (IMRT): CENTRAL NERVOUS SYSTEM TUMORS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197010-34B65DA202 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR FMR1 AND FMR2 VARIANTS (INCLUDING FRAGILE X AND FRAGILE XE SYNDROMES)PayerPolicy · BCBSM-2034253-4AC8FC5445 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | REDUCTION MAMMAPLASTY (BREAST REDUCTION) FOR BREAST-RELATED SYMPTOMS (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210524-CBD8F74084 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TELEMONITORING - REMOTE PATIENT MONITORING AND REMOTE THERAPEUTIC MONITORING (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210526-847A14B74F | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MICROPROCESSOR-CONTROLLED & POWER PROSTHESES AND ORTHOSES FOR THE LOWER LIMB (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210514-FC0BFFFF36 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TELEMONITORING- REMOTE PATIENT MONITORING AND REMOTE THERAPEUTIC MONITORING (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209365-49658463AA | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAOPERATIVE NEUROPHYSIOLOGIC MONITORING (SENSORY-EVOKED POTENTIALS, MOTOR-EVOKED POTENTIALS, EEG MONITORING)PayerPolicy · BCBSM-2026111-A8362DF418 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY-MODULATED RADIATION THERAPY (IMRT): CANCER OF THE HEAD AND NECK OR THYROID - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193814-F30E42890B | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LAPAROSCOPIC, PERCUTANEOUS, AND TRANSCERVICAL TECHNIQUES FOR UTERINE FIBROID MYOLYSIS (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210521-DAAB072081 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RECONSTRUCTIVE BREAST SURGERY AND MANAGEMENT OF BREAST IMPLANTS (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210510-0124AB3C06 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW/HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MISCELLANEOUS SOLID TUMORS IN ADULTSPayerPolicy · BCBSM-2019829-5ED265FE92 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - ANALYSIS OF MGMT PROMOTER METHYLATION IN MALIGNANT GLIOMAS- MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198885-004E9F086D | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BARIATRIC SURGERY (GASTRIC SURGERY FOR MORBID OBESITY) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209360-F7A33774D8 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | OPTICAL COHERENCE TOMOGRAPHY (OCT) OF THE BREAST AND/OR AXILLARY LYMPH NODES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197632-B364799DE9 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY-MODULATED RADIATION THERAPY (IMRT): ABDOMEN, PELVIS, AND CHEST - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193858-4C26481994 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR TAY-SACHS DISEASE (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209357-AB8E3155A0 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MENISCAL ALLOGRAFTS AND OTHER MENISCAL IMPLANTS (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209359-8FFEFCF3B6 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SPEECH AND LANGUAGE PATHOLOGY/SWALLOWING REHABILITATION (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210511-6C589835B7 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW TRANSPLANT HEMATOPOIETIC CELL TRANSPLANTATION FOR EPITHELIAL OVARIAN CANCERPayerPolicy · BCBSM-2026842-9FD3019F20 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CRYOABLATION OR CRYONEUROLYSIS (E.G., IOVERA° SYSTEM) OF PERIPHERAL NERVES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193020-591A67CA8A | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PERORAL ENDOSCOPIC MYOTOMY FOR TREATMENT OF ESOPHAGEAL ACHALASIA OR GASTROPARESIS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194115-D31D2593C2 | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY MODULATED RADIATION THERAPY (IMRT) OF THE BREAST AND LUNG - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193813-7B2FB4613C | Retired |
|---|
| Sep 30, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | STEREOTACTIC RADIOSURGERY AND STEREOTACTIC BODY RADIOTHERAPY (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209364-217550DAE6 | Retired |
|---|